1. Home
  2. CKPT vs TWI Comparison

CKPT vs TWI Comparison

Compare CKPT & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CKPT
  • TWI
  • Stock Information
  • Founded
  • CKPT 2014
  • TWI 1890
  • Country
  • CKPT United States
  • TWI United States
  • Employees
  • CKPT N/A
  • TWI N/A
  • Industry
  • CKPT Biotechnology: Pharmaceutical Preparations
  • TWI Steel/Iron Ore
  • Sector
  • CKPT Health Care
  • TWI Industrials
  • Exchange
  • CKPT Nasdaq
  • TWI Nasdaq
  • Market Cap
  • CKPT 361.1M
  • TWI 414.7M
  • IPO Year
  • CKPT 2017
  • TWI 1993
  • Fundamental
  • Price
  • CKPT $4.26
  • TWI $7.24
  • Analyst Decision
  • CKPT Buy
  • TWI Strong Buy
  • Analyst Count
  • CKPT 3
  • TWI 2
  • Target Price
  • CKPT $4.33
  • TWI $11.00
  • AVG Volume (30 Days)
  • CKPT 2.1M
  • TWI 479.1K
  • Earning Date
  • CKPT 05-13-2025
  • TWI 04-30-2025
  • Dividend Yield
  • CKPT N/A
  • TWI N/A
  • EPS Growth
  • CKPT N/A
  • TWI N/A
  • EPS
  • CKPT N/A
  • TWI N/A
  • Revenue
  • CKPT $41,000.00
  • TWI $1,854,436,000.00
  • Revenue This Year
  • CKPT $102,182.93
  • TWI $2.22
  • Revenue Next Year
  • CKPT $351.71
  • TWI $5.78
  • P/E Ratio
  • CKPT N/A
  • TWI N/A
  • Revenue Growth
  • CKPT N/A
  • TWI 5.64
  • 52 Week Low
  • CKPT $1.80
  • TWI $5.93
  • 52 Week High
  • CKPT $4.50
  • TWI $9.60
  • Technical
  • Relative Strength Index (RSI)
  • CKPT 80.26
  • TWI 49.35
  • Support Level
  • CKPT $4.14
  • TWI $6.83
  • Resistance Level
  • CKPT $4.20
  • TWI $7.45
  • Average True Range (ATR)
  • CKPT 0.03
  • TWI 0.23
  • MACD
  • CKPT -0.00
  • TWI 0.02
  • Stochastic Oscillator
  • CKPT 85.71
  • TWI 35.84

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

Share on Social Networks: